breast cancer
Conditions
Interventions
Thoracic wall block with 0.25% levobupivacaine was performed in the anesthesia for Thoracic wall block with 0.25% levobupivacaine was performed in the anesthesia for breast cancer sugery
As control, t
Sponsors
Niigata University Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: The female patients who will undergo breast cancer surgery in Niigata University Hospital (from 20 y.o to 80 y.o.)
Exclusion criteria
Exclusion criteria: The patient who disagree to participate in this study ASA-physical status =/>4 The patient who has difficulty for communication (eg. patient suffered from dementia, has mental retardation, can not understand Japanese) Body Mass Index >30kg/m2 Body Weight<40kg The patient has allergy for the drugs that will use in this study Renal dysfunction or hepatic dysfunction The patient who has abnormal sensation or hypoesthesia in body trunk The patient who is received opioid medication The patient whom the examiner assume inadequate to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| intraoperative: dose of anesthetics (propofol) and opioid (remifentanil) postoperative: incidence of usage of adjuvant analgesics and spontaneous pain scale (numerical rating scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| intraoperative: anesthetic induction time postopreative: incidence and degree of postoperative nausea and vomiting, incidence of adverse event and incidence and degree of persistent postoperative pain at 1,3 and 6 month after surgery | — |
Countries
Japan
Contacts
Public ContactHiroshi Baba
Niigata University Graduate School of Medical and Dental Science Anesthesiology
Outcome results
None listed